16:44 EST Cogent Biosciences (COGT) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences Advances Precision Therapies in Q3 2025
- Cogent Biosciences: Hold Rating Amid Anticipated Positive Data and Pipeline Developments
- Cogent Biosciences reports Q3 net loss $80.9M vs. $70.6M last year
- Cogent Biosciences sees cash runway into 2027
- Cogent Biosciences Advances FGFR2/3 Inhibitor Study in Cancer Treatment